Navigation Links
Drugs to Tackle Anemia may Be Playing Dracula

The FDA has issued the ‘black box’ warning- the highest level of warning, to the genetically engineered drugs, erythtropoietins//, that are meant to counteract anemia.

These drugs, such as Epo, are given to patients suffering from anemia caused by chemotherapy and kidney failure. They are hormone-based drugs, usually derived from kidneys.

It was seen that there was a more than a warranted number of complications such as blood clots, strokes heart attacks and even early death arising from over use of the drug. This was seen especially in patients with chronic kidney failure.

These drugs are among the top 3 selling drugs in the U.S and major producers Amgen and Johnson and Johnson reported record sales of 10 billion dollars last year.

The drugs are advertised directly to consumers, even though they are extremely expensive and given only by injection.

Recent studies suggest that the drugs, which are commonly prescribed to cancer patients receiving chemotherapy, may actually make tumors grow faster and increase the risk of death, if given in high doses. This is according to the FDA’s official Richard Pazdur, who announced the new "black box' warning.

The ‘black box’ warning cautions that the drugs should be used at the lowest dose necessary to avoid the need for a blood transfusion. They should not be used to fully reverse anemia.

The FDA’s public health advisory yesterday could now mean that physicians are likely to be more light-handed in their use of these drugs.

'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... ... ... Georgia Urology, the largest urology practice in the Southeastern United States, ... East Cobb (4800 Olde Towne Parkway, Suite 220, Marietta). , “Georgia Urology ... Georgia Urology’s managing partner. “She brings a passionate, fresh perspective on general urology to ...
(Date:8/17/2017)... ... August 17, 2017 , ... Brookfield, WI-based RF Technologies ... and education, is celebrating its 30th year in business this month. , The ... companies Square D, Allis Chalmers and Johnson Controls. Following his years in the ...
(Date:8/17/2017)... PA (PRWEB) , ... August 17, 2017 , ... ... Expo is an opportunity for IDNs and healthcare systems to interact with their ... Hayes, Inc. and Karla Barber, RN, BCN, CVAHP, System Director of Clinical Value ...
(Date:8/17/2017)... ... August 17, 2017 , ... The Skoll Foundation, TED, ... systems change models helping to achieve progress towards the Sustainable Development Goals (SDGs). ... the Future: Accelerating Sustainable Development Solutions” at TED Theater in New York, and ...
(Date:8/17/2017)... ... August 17, 2017 , ... In its just released 2018 Edition, The ... Nelson. This is the third consecutive year that Hardiman and Mills have been honored ... recognized for expertise in Health Care Law while Mills was recognized in the Administrative ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... Fenita J. Caldwell is ... Lifetime Professional in the Field of Healthcare. Caldwell ... Pharmaceuticals, AG. Her skills and areas of expertise ... Fenita ... experience as a highly successful sales specialist in ...
(Date:7/31/2017)... , July 31, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan by Crain,s Detroit Business ... and public companies by three-year revenue growth. This year,s edition ... To view the complete list, visit crainsdetroit.com/awards/fast_50/2017 ... is an incredible triumph," said Phil Hagerman , CEO ...
(Date:7/27/2017)... Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results ... reported second quarter net sales of $1.954 billion, an ... an increase of 2.1% on a constant currency basis.  ... LDR Holding Corporation acquisition, second quarter 2017 revenues decreased ... on a constant currency basis. ...
Breaking Medicine Technology: